Profile
Rémi Droller is currently the Chairman at Dyncaure SAS, Director at Sterispine, Director at Imcheck Therapeutics SAS, Director at Vico Therapeutics BV, Director at Flamingo Therapeutics BV, Director at Pharvaris GmbH, Member-Supervisory Board at AM-Pharma Holding BV, Member-Supervisory Board at AM-Pharma BV, Managing Partner at Kurma Partners SA, and Member-Supervisory Board at Dynacure SA. He previously held positions as Chairman at Step Pharma SAS, Director at IntegraGen SA, Director at Valerio Therapeutics SA, Director at Zealand Pharma A, Director at Domain Therapeutics SA, Director at Novagali Pharma SA, Director at Theradiag SA, Director at OxThera AB, Director at Adocia SA, Independent Director at Orphazyme A, Director at STAT-Dx Life SL, Director at Key Neurosciences SAS, Non-Executive Director at Pharvaris NV, Partner at Eurazeo Investment Manager - EIM SA, Member-Supervisory Board at Prosensa Holding NV, and Head-Analysis at CDC Entreprises Innovation.
Dr. Droller graduated from Université Pierre et Marie Curie, AgroParisTech, and Nova School of Business & Economics.
Rémi Droller active positions
| Companies | Position | Start |
|---|---|---|
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance KP invests in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. It provides financing for seed to growth stage capital requirements. | Private Equity Investor | 2010-08-31 |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Director/Board Member | - |
Sterispine | Director/Board Member | - |
Dyncaure SAS
Dyncaure SAS Pharmaceuticals: MajorHealth Technology Manufactures non-therapeutic products | Chairman | - |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Director/Board Member | - |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Director/Board Member | - |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Director/Board Member | - |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | 2016-03-31 |
Former positions of Rémi Droller
| Companies | Position | End |
|---|---|---|
| PHARVARIS N.V. | Director/Board Member | 2021-12-21 |
| ░░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░ ░░░░░░░ ░ ░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Rémi Droller
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 29 |
|---|---|
IntegraGen SA
IntegraGen SA Medical/Nursing ServicesHealth Services Develops cutting edge genome analysis products | Health Services |
Valerio Therapeutics SA
Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
Eurazeo Investment Manager - EIM SA
Eurazeo Investment Manager - EIM SA Investment ManagersFinance Eurazeo Investment Manager is an active, long-term manager which invests in the information technology and life sciences sectors, aiming to invest in businesses with quality management teams, high potential in their target market and the capacity to maintain their competitive advantage. EIM invests in European small to medium sized companies providing venture capital at all stages, growth capital and debt financing. The firm also invests in funds throughout primary and secondary transactions. | Finance |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Domain Therapeutics SA
Domain Therapeutics SA BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that manufacture immuno-oncology and inflammation products | Health Technology |
Novagali Pharma SA
Novagali Pharma SA Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for eye treatment | Health Technology |
Theradiag SA
Theradiag SA Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostic products | Health Technology |
AM-Pharma Holding BV
AM-Pharma Holding BV Pharmaceuticals: MajorHealth Technology Engages in financial investment and shareholding activities | Health Technology |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Prosensa Holding NV
Prosensa Holding NV BiotechnologyHealth Technology Engages in the development of ribonucleic acid-modulating or RNA-modulating, therapeutics for the treatment of genetic disorders | Health Technology |
OxThera AB
OxThera AB Medical/Nursing ServicesHealth Services Develops novel treatments for hyperoxaluria leading to kidney damage and potential organ failure | Health Services |
Adocia SA
Adocia SA Pharmaceuticals: MajorHealth Technology Manufactures novel therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases | Health Technology |
AM-Pharma BV
AM-Pharma BV BiotechnologyHealth Technology Provides biopharmaceutical products | Health Technology |
Kurma Partners SA
Kurma Partners SA Investment ManagersFinance KP invests in startups located in Europe. The firm targets companies operating in the fields of healthcare services and health technologies. It provides financing for seed to growth stage capital requirements. | Finance |
AgroParisTech
AgroParisTech Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Strategic Partners A/S
Strategic Partners A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic treatment of of diseases caused by defects in the function and metabolism of proteins | Health Technology |
CDC Entreprises Innovation
CDC Entreprises Innovation Financial ConglomeratesFinance Provides investment services | Finance |
STAT-Dx Life SL
STAT-Dx Life SL Medical SpecialtiesHealth Technology Develops molecular and immunoassay diagnostic systems for clinical decentralized testing | Health Technology |
Sterispine | |
Key Neurosciences SAS
Key Neurosciences SAS Miscellaneous Commercial ServicesCommercial Services Provides research and development services | Commercial Services |
Nova School of Business & Economics
Nova School of Business & Economics Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharvaris NV
Pharvaris NV BiotechnologyHealth Technology Develops and commercializes oral bradykinin B2 receptor antagonists | Health Technology |
Step Pharma SAS
Step Pharma SAS Pharmaceuticals: MajorHealth Technology Develops drugs for immunosuppressive therapies | Health Technology |
Imcheck Therapeutics SAS
Imcheck Therapeutics SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops immunotherapeutic anti-cancer strategies for research | Health Technology |
Dynacure SA
Dynacure SA Medical/Nursing ServicesHealth Services Develops novel therapies to transform the lives of patients | Health Services |
Dyncaure SAS
Dyncaure SAS Pharmaceuticals: MajorHealth Technology Manufactures non-therapeutic products | Health Technology |
Vico Therapeutics BV
Vico Therapeutics BV BiotechnologyHealth Technology Develops ribonucleic acid modulating therapies | Health Technology |
Flamingo Therapeutics BV
Flamingo Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Provides RNA therapeutic drug development services | Commercial Services |
Pharvaris GmbH
Pharvaris GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Rémi Droller
















